Vitamin B12, Folic Acid and Vitamin D Status in Women of Reproductive Age

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-49
SponsorUniversity of Mostar

About this trial

This cross-sectional observational study aims to assess serum concentrations of vitamin B12, folic acid, and vitamin D in women of reproductive age in Herzegovina. The study is led by Professor Vajdana Tomić, MD, PhD, who serves as the Principal Investigator, at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina. The goal is to determine whether current international supplementation guidelines reflect the actual micronutrient status of this population. A total of 360 women aged 18-49 will be enrolled between December 2024 and December 2025 after providing informed consent. The findings will inform population-specific recommendations for micronutrient supplementation during the preconception period and pregnancy.

The study will be conducted at the Faculty of Health Studies, University of Mostar, Bosnia and Herzegovina.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Women of reproductive age (18-49 years)

Informed consent obtained

Disqualifiers

diabetes (Type I or II)

epilepsy

oncological diseases, inflammatory bowel disease

supplementation with vitamin B12, folic acid, or vitamin D within the last 3 months

Trial population

This study includes approximately 360 healthy women aged 18 to 49 years from the Herzegovina region who participate after providing written informed consent. All participants are being screened according to defined inclusion and exclusion criteria. The study focuses on assessing serum concentrations of vitamin B12, folic acid, and vitamin D to support the development of population-specific supplementation guidelines for the preconception period and pregnancy.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • No Interventions

    Other intervention

    This is an observational study. No intervention will be administered. Participants will provide blood samples for micronutrient analysis.

Treatment groups

360 Participants
are divided into 1 treatment group
Group A: Women of Reproductive Age1 intervention

Trial outcomes

Primary outcomes

1

Serum concentration of folic acid

Measured in serum samples using Alinity i immunoassay system.

Time frame
At enrollment (single visit)
2

Serum concentration of vitamin B12

Measured in serum samples using Alinity i immunoassay system.

Time frame
At enrollment (single visit)
3

Serum concentration of vitamin D

Measured in serum samples using Alinity i immunoassay system.

Time frame
At enrollment (single visit)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Mostar

Lead sponsor

Faculty of Health Studies - University of Mostar

Collaborator

Primary Health Care Center Mostar

Collaborator

University Clinical Hospital Mostar

Collaborator